ENGOT-EN5/GOG- 3055/SIENDO
Trial Description:
A randomized, double-blind, phase 3 trial of maintenance with selixexor/placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer.
Lead Cooperative Group:
Trial Number:
Disease Site:
Endometrial
Trial Status:
Closed to Recruitment
Contact person:
ivergote